Paravertebral Block for Breast Surgery

This study has been completed.
Sponsor:
Information provided by:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT00131170
First received: August 15, 2005
Last updated: July 4, 2007
Last verified: July 2007
  Purpose

The effect of paravertebral block in combination with general anaesthesia is studied in a double blind fashion.


Condition Intervention Phase
Breast Cancer
Procedure: paravertebral block
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Nausea and vomiting 2 hours postoperatively, and 1 and 2 days postoperatively [ Time Frame: 2 days ]

Secondary Outcome Measures:
  • Dosage of analgesic [ Time Frame: 1 day ]

Enrollment: 90
Study Start Date: September 2005
Study Completion Date: September 2006
Detailed Description:

Patients having surgery for breast cancer receive a paravertebral blockade at C8-Th4 with either Naropin 0.5% or saline. General anaesthesia is then provided with laryngeal mask intubation, propofol infusion and fentanyl i.v. as needed. The effect on postoperative pain ([VAS] and fentanyl PCA doses taken) and postoperative nausea and vomiting is recorded.

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Breast surgery

Exclusion Criteria:

  • Infections
  • Coagulation disorder
  • Allergy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00131170

Locations
Denmark
Dept of Anesthesiology, Aarhus University Hospital
Aarhus, Denmark, DK 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Principal Investigator: Palle Carlsson, MD Dr Sci Dept anesthesiology, Arhus University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00131170     History of Changes
Other Study ID Numbers: PVB1
Study First Received: August 15, 2005
Last Updated: July 4, 2007
Health Authority: Denmark: National Board of Health

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on August 18, 2014